首页> 美国卫生研究院文献>European Journal of Human Genetics >Managing clinically significant findings in research: the UK10K example
【2h】

Managing clinically significant findings in research: the UK10K example

机译:管理研究中具有临床意义的发现:UK10K示例

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Recent advances in sequencing technology allow data on the human genome to be generated more quickly and in greater detail than ever before. Such detail includes findings that may be of significance to the health of the research participant involved. Although research studies generally do not feed back information on clinically significant findings (CSFs) to participants, this stance is increasingly being questioned. There may be difficulties and risks in feeding clinically significant information back to research participants, however, the UK10K consortium sought to address these by creating a detailed management pathway. This was not intended to create any obligation upon the researchers to feed back any CSFs they discovered. Instead, it provides a mechanism to ensure that any such findings can be passed on to the participant where appropriate. This paper describes this mechanism and the specific criteria, which must be fulfilled in order for a finding and participant to qualify for feedback. This mechanism could be used by future research consortia, and may also assist in the development of sound principles for dealing with CSFs.
机译:测序技术的最新进展使人类基因组数据的生成比以往更快,更详细。这样的细节包括可能对相关研究参与者的健康具有重要意义的发现。尽管研究通常不会将有关临床意义的发现(CSF)的信息反馈给参与者,但这一立场越来越受到质疑。将临床上重要的信息反馈给研究参与者可能会有困难和风险,但是,UK10K财团试图通过创建详细的管理途径来解决这些问题。这并不是要给研究人员提供任何义务来反馈他们发现的任何脑脊液。相反,它提供了一种机制,以确保在适当的情况下可以将任何此类发现传递给参与者。本文描述了这种机制和特定标准,必须满足这些标准,以使发现和参与者有资格获得反馈。未来的研究财团可以使用这种机制,也可以协助制定处理CSF的合理原则。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号